Intellia Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics leveraging CRISPR-based technologies, today announced that the company is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 2:15 p.m. ET.

A live audio webcast of Intellia’s presentation can be accessed under the Events and Presentations page of the Investors & Media section on the company’s website. A replay of the audio webcast will be available on Intellia’s website for at least two weeks following the presentation.

Stay Up To Date:

Receive the latest news and developments in treatment and care

Featured Resources

FAQs

1 The Core Members of an Amyloidosis Care Team ?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

2 What Treatment Options are Available for Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

3 How is Amyloidosis Diagnosed?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

4 What Specialists Are Involved in the Treatment of Amyloidosis?

Find resources, support groups, and organizations that offer information, assistance, and a community for Amyloidosis patients and their families.

Patient Care Center

Intellia Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022

Stay Up To Date:

Featured Resources

Caregiver Support : Taking care of yourself

Caregiver Support : Taking care of yourself

FAQs

Patient Affair Directory

Video Library